Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Girding For MDUFMA II: Premarket Review Unit Cost Study In Planning Phase

This article was originally published in The Gray Sheet

Executive Summary

FDA's unit cost analysis of premarket review resources may incite a long-term change to device user fee rates if certain application types prove more expensive to assess than previously believed

You may also be interested in...



PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules

FDA's cost study of its device review resources likely will consolidate labor data for traditional, modular, expedited and panel-track PMAs into one cohort, rather than track each application type separately

PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules

FDA's cost study of its device review resources likely will consolidate labor data for traditional, modular, expedited and panel-track PMAs into one cohort, rather than track each application type separately

CDRH Contracts Review Cost Auditor; Expedited, Modular PMAs On The Rise

FDA's device center is meeting review targets for expedited premarket applications, with just over a quarter of the fiscal 2004 cohort completed

Related Content

UsernamePublicRestriction

Register

MT020617

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel